| 000 | 01676 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516193230.0 | ||
| 264 | 0 | _c20140929 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0087068 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHusni, Nicholas R | |
| 245 | 0 | 0 |
_aFibroblasts from type 1 diabetics exhibit enhanced Ca(2+) mobilization after TNF or fat exposure. _h[electronic resource] |
| 260 |
_bPloS one _c2014 |
||
| 300 |
_ae87068 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBradykinin _xmetabolism |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aDermis _xcytology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFatty Acids, Nonesterified _xpharmacology |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Bradykinin _xmetabolism |
| 650 | 0 | 4 | _aSiblings |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aThapsigargin _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aJones, Albert R | |
| 700 | 1 | _aSimmons, Amber L | |
| 700 | 1 | _aCorkey, Barbara E | |
| 773 | 0 |
_tPloS one _gvol. 9 _gno. 1 _gp. e87068 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0087068 _zAvailable from publisher's website |
| 999 |
_c23488086 _d23488086 |
||